News

Dr. Lee Hood Writes ‘Second Opinion’ Columns for Los Angeles Times

ISB Co-founder, Chief Strategy Officer and Professor Dr. Lee Hood is credited with coining the term “systems biology,” and has been a longtime advocate of P4 medicine (predictive, preventive, personalized and participatory).

Now, Hood has been selected by the Los Angeles Times to share his insights in a new weekly op-ed column, called Second Opinion.

The column “aims to engage cutting-edge debates about the unprecedented global challenges that our society faces” and “will feature contributions from thought leaders, scientists, diplomats, humanitarians, artists, economists, and other experts who will offer their insights into these challenges, in an effort to identify solutions and actions to solve them,” said Dr. Patrick Soon-Shiong, executive chairman of the L.A. Times, in an article announcing the weekly column.

Hood has penned two columns, and more are in the works. The Second Opinion columns are published in print in Sunday Los Angeles Times newspapers and appear on latimes.com. They are also syndicated by Yahoo News and many other outlets. Prior to the launch of Second Opinion, Hood and author Matthew LaPlante wrote an op-ed for the Los Angeles Times.

Dr. Hood’s Columns:

 

Claire Reid / Los Angeles Times; Getty Images, Unsplash

Image Courtesy Claire Reid / Los Angeles Times; Getty Images, Unsplash

Op-Ed: The key to treating Alzheimer’s disease may not be a drug
June 30, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Nicole Vas

Second Opinion: How long haul COVID could offer clues for treating other puzzling illnesses
April 18, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Science Photo Library / Associated Press

Second Opinion: Getting past disease to the science of wellness
March 21, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Associated Press

Op-Ed: How science education can stave off demagogues
January 24, 2021

Read more

Recent Articles

  • Nir Barzilai on Health Span, Life Span and the New Science of Longevity

    Longevity and aging researcher Dr. Nir Barzilai participated in a fireside chat conversation with ISB Co-founder and Professor Dr. Lee Hood. The two renowned scientists talked about Barzilai’s study of 750 centenarians, how aging research has changed over the years, and what exciting developments are coming.

  • Microbiome and weight loss

    Can You Lose Weight? Ask Your Microbiome

    The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome. These new findings open the door to diagnostic tests that can identify people likely to lose weight with healthy lifestyle changes and those who might need more drastic interventions.

  • Drs. Jim Heath, Yapeng Su and Jihoon Lee

    Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival

    Researchers from Institute for Systems Biology (ISB), Fred Hutchinson Cancer Research Center and other organizations have uncovered underlying metabolic changes that regulate how immune cells react to COVID-19. These findings are associated with COVID-19 severity and may predict patient survival. The work was published in the journal Nature Biotechnology.